14 companies were scheduled to go public this week, including 10 health care deals. Only 8 IPOs got through, as 3 biotechs have been pushed back to next week, two companies postponed and one withdrew. however; IPO investors had plenty of options while the NASDAQ...read more
Collegium Pharmaceutical, which is developing an abuse-deterrent oral formulation of oxycodone for pain, raised $70 million by offering 5.8 million shares at $12, the low end of the range of $12 to $14. Collegium Pharmaceutical plans to list on the NASDAQ under...read more
This could be the busiest 5-day stretch in the IPO market since the week of July 28, 2014, as 14 companies look to raise nearly $2 billion. However, ...read more
Collegium Pharmaceutical, which is developing an abuse-deterrent oral formulation of oxycodone for pain, announced terms for its IPO on Monday.
The Canton, MA-based company plans to raise $75 million by offering 5.8 million shares at a price range of $12 to...read more
US IPO Weekly Recap: With 8 IPOs it's Bo-Time for Bojangles and no time for biotechs
14 companies were scheduled to go public this week, including 10 health care deals. Only 8 IPOs got through, as 3 biotechs have been pushed back to next week, two companies postponed and one withdrew. however; IPO investors had plenty of options while the NASDAQ...read more
Collegium Pharmaceutical prices IPO at $12, the low end of the range
Collegium Pharmaceutical, which is developing an abuse-deterrent oral formulation of oxycodone for pain, raised $70 million by offering 5.8 million shares at $12, the low end of the range of $12 to $14. Collegium Pharmaceutical plans to list on the NASDAQ under...read more
Week ahead: 14 IPOs planned for the week of May 4
This could be the busiest 5-day stretch in the IPO market since the week of July 28, 2014, as 14 companies look to raise nearly $2 billion. However, ...read more
Collegium Pharmaceutical sets terms for $75 million IPO
Collegium Pharmaceutical, which is developing an abuse-deterrent oral formulation of oxycodone for pain, announced terms for its IPO on Monday. The Canton, MA-based company plans to raise $75 million by offering 5.8 million shares at a price range of $12 to...read more